46 results on '"Barth, R."'
Search Results
2. Transient Utilization of Belatacept Facilitates Renal Recovery in Liver Transplant Recipients.
3. Intraoperative Continuous Veno-Venous Hemofiltration Facilitates Surgery in Liver Transplant Patients With Acute Renal Failure.
4. Five Year Experience With Single-Port Donor Nephrectomy as a Standardized Approach.
5. Shorter Waitlist Time for HCV+ Renal Allografts Improves Long-Term Graft Survival Without Associated Progression of Clinical Liver Disease.
6. Live Donor Renal Transplant With Simultaneous Bilateral Nephrectomy for APKD: 10-Year Experience.
7. Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
8. Transient Detection of Microchimerism Using Quantitative RT-PCR for Insertion/Deletion Polymorphysms After Full Face Transplant.
9. Pig-to-Baboon Liver Xenoperfusion Utilizing GalTKO.hCD46 Pigs and Glycoprotein Ib Blockade.
10. PANCREAS TRANSPLANT ALONE (PTA) AS AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF RENAL FAILURE
11. PROLONGED SURVIVAL OF COMPOSITE TISSUE ALLOGRAFTS ASSOCIATED WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN A NON-HUMAN PRIMATE MODEL
12. DONATION AFTER CARDIAC DEATH LIVER TRANSPLANTATION DOES NOT INFLUENCE EARLY HEPATITIS C RECURRENCE OR OUTCOMES
13. PREDICTING GRAFT OUTCOME WITH EVALUATION OF PRE-TRANSPLANT KIDNEY BIOPSY USING A CUMULATIVE PATHOLOGY SCORE
14. SUCCESSFUL ALEMTUZUMAB INDUCTION AND STEROID WITHDRAWAL IN AFRICAN AMERICAN AND CAUCASIAN RECIPIENTS OF RENAL TRANSPLANTS
15. HCV+ RENAL TRANSPLANT PATIENTS DO NOT PROGRESS TO LIVER CIRRHOSIS FOLLOWING T-CELL DEPLETION
16. VOLUME-OUTCOME RELATIONSHIP IN THE PROCUREMENT OF TRANSPLANTABLE ORGANS
17. ENHANCED CD4 RECONSTITUTION BY GRAFTING NEONATAL PORCINE TISSUE IN ALTERNATIVE LOCATIONS IS ASSOCIATED WITH DONOR-SPECIFIC TOLERANCE AND SUPPRESSION OF PREEXISTING XENOREACTIVE T CELLS1
18. ENHANCED CD4 RECONSTITUTION BY GRAFTING NEONATAL PORCINE TISSUE IN ALTERNATIVE LOCATIONS IS ASSOCIATED WITH DONOR-SPECIFIC TOLERANCE AND SUPPRESSION OF PREEXISTING XENOREACTIVE T CELLS1.
19. B-cell reconstitution and xenoreactive anti-pig natural antibody production in severe combined immunodeficient mice reconstituted with immunocompetent B cells from varying sources.
20. Studies on heterologous antilymphocyte and antithymocyte sera.IV. Further evidence for a preferential effect on antigen sensitive cells
21. The Effect of Induction Therapy on Pancreas Transplantation Outcomes: Lessons Learned Following a Decade of Change.
22. Improved Efficiency of LigaSure Vessel Sealing System for Recipient Hepatectomy in Liver Transplantation.
23. Infused Bone Marrow Fails to Prolong Vascularized Composite Allograft Survival in Nonhuman Primates.
24. Multi-Organ and Complex Full Facial Segment Procurement from a Brain Dead Donor.
25. PNAd Expression in the Skin of Human Hand and Nonhuman Primates Vascularized Composite Allografts.
26. Vascularized Bone Marrow Does not Protect Renal Allografts in Unconditioned Non-Human Primates.
27. VALIDATION OF THE MARYLAND AGGREGATE PATHOLOGY INDEX (MAPI) ON PRE-IMPLANTATION BIOPSIES (PIB) AS A PREDICTOR OF GRAFT OUTCOME AT TWO INDEPENDENT TRANSPLANT CENTERS.
28. THE INFLUENCE OF DONOR TYPE ON URETERAL COMPLICATIONS AFTER KIDNEY TRANSPLANTATION.
29. SAFE AND ROUTINE APPLICATION OF LAPAROENDOSCOPIC SINGLE SITE (LESS) DONOR NEPHRECTOMIES: EXPERIENCE WITH 60 CASES.
30. THE MARYLAND AGGREGATE PATHOLOGY INDEX (MAPI) IS SUPERIOR TO THE KIDNEY DONOR RISK INDEX (KDRI) AS A PREDICTOR OF GRAFT OUTCOME.
31. FLUORESCENT IMAGING OF NON-HUMAN PRIMATE COMPOSITE TISSUE ALLOGRAFTS DEMONSTRATES PROLONGED GRAFT LYMPHEDEMA INDEPENDENT OF REJECTION.
32. PILOT EVALUATION OF ANTI-GPIB EFFECTS ON PLATELET SEQUESTRATION IN AN EX VIVO XENOGENEIC PIG LIVER PERFUSION MODEL.
33. CHRONIC REJECTION IN A NON-HUMAN PRIMATE MODEL OF FACIAL COMPOSITE TISSUE ALLOTRANSPLANTATION: CLINICAL, PATHOLOGICAL, AND IMMUNOHISTOCHEMICAL CHARACTERIZATION.
34. COSTIMULATORY BLOCKADE DOES NOT PROMOTE SURVIVAL OF SKIN COMPONENT IN NON-HUMAN-PRIMATE COMPOSITE TISSUE ALLOGRAFTS.
35. A BANFF CV2 LESION IN A PRE-IMPLANTATION BIOPSY IS THE BEST PREDICTOR OF DELAYED GRAFT FUNCTION FOLLOWING RENAL TRANSPLANTATION.
36. CAMPATH INDUCTION DOES NOT PREDISPOSE TO CYTOMEGALOVIRUS DISEASE.
37. LIVING KIDNEY DONOR RELATIONSHIPS IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS AND IMPLICATIONS FOR TARGETED DONOR EDUCATION PROGRAMS.
38. GERIATRIC RECIPIENTS OF DECEASED DONOR RENAL TRANSPLANTS DEMONSTRATE EQUAL GRAFT SURVIVAL TO NON-GERIATRIC POPULATIONS.
39. ANTIBODY-MEDIATED REJECTION (AMR): RISK FACTORS AND IMPACT ON GRAFT (Tx) AND PATIENT (Pt) SURVIVAL.
40. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.
41. Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine.
42. The induction of specific pig skin graft tolerance by grafting with neonatal pig thymus in thymectomized mice.
43. Thymic transplantation in miniature swine. I. Development and function of the "thymokidney".
44. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
45. Specific and nonspecific cytotoxicity of leukocytes from human renal allograft recipients against donor fibroblasts.
46. Correlation of spontaneous leukocyte blastogenesis with human renal allograft rejection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.